raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:585918

B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)

Synonyms: B Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A Rearranged · B lymphoblastic leukemia lymphoma with t(v;11q23); MLL rearranged

Type
Etiological subtype
Group
Subtype of disorder
Inheritance
Not applicable
Age of onset
Adolescent, Adult, Childhood, Infancy
Status
active

Orphadata ships no English definition for this code.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enB-lymphoblastic leukemia/lymphoma with t(v;11q23.3)B Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A Rearranged · B lymphoblastic leukemia lymphoma with t(v;11q23); MLL rearranged
frLeucémie/lymphome lymphoblastique B associé à t(v;11q23.3)Leucémie/lymphome lymphoblastique B avec t(v;11q23.3) · Lymphome/leucémie lymphoblastique à cellules B avec t(v;11q23); MLL réarrangé
deB-lymphoblastische Leukämie/Lymphom mit t(v;11q23.3)B-lymphoblastische Leukämie/Lymphom mit t(v;11q23); MLL-Rearrangement · B-lymphoblastische Leukämie/Lymphom mit t(v;11q23.3); KMT2A-Rearrangement
esLeucemia/linfoma linfoblástico de células B con t(v;11q23.3)Leucemia/linfoma linfoblástico de células B con t(v;11q23); reordenamiento del gen MLL · Leucemia/linfoma linfoblástico de células B con t(v;11q23.3); reordenamiento del gen KMT2A
itLeucemia linfoblastica a cellule B/linfoma con t(v;11q23.3)Leucemia linfoblastica a cellule B/linfoma con t(v;11q23.3); con riarrangiamenti in KMT2A · Leucemia linfoblastica a cellule B/linfoma con t(v;11q23.3); con riarrangiamenti in MLL
nlB-lymfoblastische leukemie/lymfoom met t(v;11q23.3)B-lymfoblastische leukemie/lymfoom met t(v;11q23); MLL herschikt · B-lymfoblastische leukemie/lymfoom met t(v;11q23.3); KMT2A herschikt
ptLeucemia/linfoma linfoblástico-B com t(v;11q23.3)
plBiałaczka/chłoniak limfoblastyczny z komórek B z t(v;11q23.3)Białaczka/chłoniak limfoblastyczny z komórek B z t(v;11q23.3); z rearanżacjami MLL · Białaczka/chłoniak limfoblastyczny z komórek B z t(v;11q23.3); z rearanżacjami KMT2A
csB-lymfoblastická leukémie/lymfom s t(v;11q23.3)= en
ukВ-лімфобластний лейкоз/лімфома з t(v;11q23.3)В лімфобластний лейкоз лімфома з t(v;11q23); MLL реаранжування · B Лімфобластний лейкоз/лімфома з t(v;11q23.3); KMT2A реаранжування
zhB-lymphoblastic leukemia/lymphoma with t(v;11q23.3)= en
trB-lymphoblastic leukemia/lymphoma with t(v;11q23.3)= en
2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10C91.0NTBTattributedvalidated
ICD-112A70.YNTBTindexvalidated
ICD-11XH8GG0Especificvalidated
MONDO0035941Evalidated
UMLSC2698309Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
KMT2APart of a fusion gene inAssessedHGNC:7132ENSG0000011805815955511q23.3lysine methyltransferase 2A30487223[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Annual incidenceUnknown—WorldwideClass onlyValidatedWHO Classification of Tumours[OTHER]_ORPHANET
Point prevalenceUnknown—WorldwideClass onlyValidatedWHO Classification of Tumours[OTHER]_ORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card